Neurotech International Share Price and Company Fundamentals



Price
$0.094
Change
0.005 (5.618%)
52 week
0.044 - 0.115

Last traded: Today at 5:10 AM

Neurotech International Limited, together with its subsidiaries, engages in the research, design, development, and manufacture of medical devices and solutions in Australia. The company is focused on development and commercializing Mente platform, a platform technology to monitor and play role in home-based therapies. Its product includes Mente Autism for the diagnosis and treatment of autism. It also engages in executing of medical research projects; and developing of technological devices. The company was incorporated in 2016 and is based in Nedlands, Australia.

Key Metrics

PE ratio

-

PB ratio

41.54

Dividend yield

0.00%

Beta

2.31

Market cap

-

Enterprise value

-

Company profile

Primary activitiesDevelopment of wearable neurotechnology devices to assist with neurological conditions such as autism.
Industry / SectorMedical Devices / Healthcare
Websitehttps://www.neurotechinternational.com
Mailing address145 Stirling Highway Suite 5 CPC Nedlands WA 6009 Australia
Phone / Fax61 8 9389 3130 / 61 8 9389 3199
Share registryAUTOMIC REGISTRY SERVICES

Dividends

More: Neurotech International Dividend history, yield and payout ratio

Dividend yield

0.00%

Dividend amount

$0.00

Payout ratio

0.00%

Neurotech International paid $0.00 dividend and the ex-dividend date was .The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.NTI dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.

NTI's forward dividend amount is $ and the forward dividend yield is . A forward dividend yield is the percentage of a company's current stock price that it expects to pay out as dividends over a certain time period, generally 12 months. Forward dividend yields are generally used in circumstances where the yield is predictable based on past instances. If not, trailing yields, which indicate the same value over the previous 12 months, are used.

Company Executives

As of Oct 2022, following are the company executives and directors listed on Neurotech International.

NameTitleAgeTotal Pay
Dr. Alexandra AndrewsChief Operating Officer331.03k
Prof. Allan Cripps A.O., AO, B.Sc., Ph.D.Chief Scientist & Innovation and Director40k
Dr. Emanuela RussoChief Scientific Officer & Member of Scientific Advisory Board
Mr. Gerald QuigleyDirector of PR & Director
Dr. Thomas Duthy M.B.A., Ph.D.Exec. Director
Mr. Peter James Lawrence Griffiths B.Sc.Chief Exec. Officer of AAT Research Ltd57
Ms. Erlyn Saromines Dawson A.C.I.S., ACIS, AGIA, B.Com., BCom., GradDipACGCompany Sec.

Profitability and management effectiveness

Profit margin

0.00%

Operating margin

-553.20%

Return on assets

-59.78%

Return on equity

-127.08%

Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.

The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.

Valuation and Trading Info

The market capitalization of Neurotech International is and its enterprise value is .

The NTI's stocks Beta value is 2.31 making it 131% more volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.

Companies similar to Neurotech International (NTI)

Neurotech International (ASX:NTI) Frequently Asked Questions

1. What is Neurotech International's Stock Symbol?

Neurotech International trades on ASX under the ticker symbol "NTI".

2. What is Neurotech International's stock price today?

One share of NTI stock can currently be purchased for approximately $0.094.

3. How can I contact Neurotech International?

Neurotech International's mailing address is 145 Stirling Highway Suite 5 CPC Nedlands WA 6009 Australia. The company can be reached via phone at 61 8 9389 3130.

4. What is Neurotech International's official website?

The official website of Neurotech International is https://www.neurotechinternational.com.

5. Which share registry manages Neurotech International's stock?

Neurotech International's stock is managed by AUTOMIC REGISTRY SERVICES.